AR and hepatocellular carcinoma: Aberrant AR/PP-mediated hepatic over-production of fructose were shown to reprogram cellular glucose-lipid metabolism to significantly affect the development of obesity, metabolic syndrome, nonalcoholic fatty liver disease, and nonalcoholic steatohepatitis [18–21], all of which are important risk factors for the development of HCC.